Citation

Lim L. Singapore General Hospital Proceedings 2007; 16(2): 88-96.

Copyright

(Copyright © 2007)

DOI

unavailable

PMID

unavailable

Abstract

Depression, a prevalent condition in cancer sufferers is unfortunately often unrecognised and untreated. Depressive symptoms can cause considerable morbidity and mortality thus giving rise to distress and reduced quality of life. Diagnosis is fraught with difficulties owing to overlaps between psychiatric and medical symptoms. One should therefore rely more on psychological symptoms and adopt an inclusive approach in diagnosing depression. Assessment should take into account medical complications which may contribute to or worsen depression as well as the availability and adequacy of social supports. Assessment of suicide risk is paramount since suicide rates are increased in the terminally ill. Psychosocial interventions play just an important a role as pharmacological treatment. Psychostimulants are of benefit. It is also important to manage pain symptoms as severe, unremitting pain may trigger depressive symptoms and suicidal action.

Language: en

Keywords

human; suicide; Suicide; quality of life; Treatment; depression; prevalence; psychosis; mortality; major depression; risk assessment; mood disorder; risk factor; Major depression; morbidity; review; anticonvulsive agent; disease association; distress syndrome; clinical feature; cancer; procarbazine; tamoxifen; vincristine; coping behavior; patient attitude; interferon; benzodiazepine; delirium; corticosteroid; cimetidine; propranolol; levodopa; antineoplastic agent; pentazocine; interleukin 2; reserpine; thiazide diuretic agent; indometacin; sulfonamide; asparaginase; vinblastine; isosorbide dinitrate; Terminal cancer